UBS Group’s NLS Pharmaceutics Ltd. Warrant NLSPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,023
| Closed | -$295 | – | 8635 |
|
|
2024
Q1 | $295 | Buy |
6,023
+5,023
| +502% | +$246 | ﹤0.01% | 7472 |
|
|
2023
Q4 | $55 | Buy |
+1,000
| New | +$55 | ﹤0.01% | 7768 |
|
|
2023
Q1 | – | Sell |
-3,745
| Closed | -$1.09K | – | 8831 |
|
|
2022
Q4 | $1.09K | Sell |
3,745
-11,802
| -76% | -$3.42K | ﹤0.01% | 8763 |
|
|
2022
Q3 | $4K | Buy |
15,547
+13,461
| +645% | +$3.46K | ﹤0.01% | 8270 |
|
|
2022
Q2 | $0 | Buy |
2,086
+96
| +5% | – | ﹤0.01% | 9554 |
|
|
2022
Q1 | $1K | Sell |
1,990
-645
| -24% | -$324 | ﹤0.01% | 8830 |
|
|
2021
Q4 | $1K | Hold |
2,635
| – | – | ﹤0.01% | 8871 |
|
|
2021
Q3 | $2K | Sell |
2,635
-711
| -21% | -$540 | ﹤0.01% | 7815 |
|
|
2021
Q2 | $3K | Buy |
3,346
+227
| +7% | +$204 | ﹤0.01% | 7714 |
|
|
2021
Q1 | $3K | Buy |
+3,119
| New | +$3K | ﹤0.01% | 7485 |
|